DSM-Firmenich Forecast, price target & analysts
DSM-Firmenich Target price 2025 - Analyst rating & recommendation
DSM-Firmenich Classifications & Recommendation:
DSM-Firmenich Price Target
| Target Price | €127.53 |
| Price | €96.00 |
| Potential |
32.84%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target DSM-Firmenich 2026 .
The average DSM-Firmenich target price is €127.53.
This is
32.84%
register free of charge
€146.00
52.08%
register free of charge
€88.00
8.33%
register free of charge
|
|
| A rating was issued by 23 analysts: 20 Analysts recommend DSM-Firmenich to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the DSM-Firmenich stock has an average upside potential 2026 of
32.84%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 12.80 | 13.43 |
| 20.44% | 4.91% | |
| EBITDA Margin | 14.44% | 18.07% |
| 16.77% | 25.15% | |
| Net Margin | 1.94% | 5.85% |
| 127.68% | 201.41% |
20 Analysts have issued a sales forecast DSM-Firmenich 2025 . The average DSM-Firmenich sales estimate is
This results in the following potential growth metrics:
20 Analysts have issued an DSM-Firmenich EBITDA forecast 2025. The average DSM-Firmenich EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 DSM-Firmenich Analysts have issued a net profit forecast 2025. The average DSM-Firmenich net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.94 | 2.97 |
| 133.33% | 215.96% | |
| P/E | 32.28 | |
| EV/Sales | 2.10 |
12 Analysts have issued a DSM-Firmenich forecast for earnings per share. The average DSM-Firmenich <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the DSM-Firmenich stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current DSM-Firmenich Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Nov 27 2024 |
| ING FM |
Locked
➜
Locked
|
Locked | Nov 26 2024 |
| HSBC |
Locked
➜
Locked
|
Locked | Nov 24 2024 |
| DEGROOF PETERCAM |
Locked
➜
Locked
|
Locked | Nov 19 2024 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
| DAY BY DAY |
Locked
➜
Locked
|
Locked | Nov 10 2024 |
| BNP PARIBAS EXANE |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Nov 27 2024 |
|
Locked
ING FM:
Locked
➜
Locked
|
Nov 26 2024 |
|
Locked
HSBC:
Locked
➜
Locked
|
Nov 24 2024 |
|
Locked
DEGROOF PETERCAM:
Locked
➜
Locked
|
Nov 19 2024 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
Nov 18 2024 |
|
Locked
DAY BY DAY:
Locked
➜
Locked
|
Nov 10 2024 |
|
Locked
BNP PARIBAS EXANE:
Locked
➜
Locked
|
Nov 07 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
